Diabetes med lixisenatide might assist sluggish Parkinson’s motor decline
Remedy with lixisenatide, a medicine authorized for kind 2 diabetes, considerably slowed the development of motor signs in other people with Parkinson’s illness in a Segment 2 medical trial. Even if gastrointestinal negative